Literature DB >> 27189939

Crystal Structure of a Two-domain Fragment of Hepatocyte Growth Factor Activator Inhibitor-1: FUNCTIONAL INTERACTIONS BETWEEN THE KUNITZ-TYPE INHIBITOR DOMAIN-1 AND THE NEIGHBORING POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN.

Zebin Hong1, Laura De Meulemeester1, Annemarie Jacobi1, Jan Skov Pedersen2, J Preben Morth3, Peter A Andreasen1, Jan K Jensen4.   

Abstract

Hepatocyte growth factor activator inhibitor-1 (HAI-1) is a type I transmembrane protein and inhibitor of several serine proteases, including hepatocyte growth factor activator and matriptase. The protein is essential for development as knock-out mice die in utero due to placental defects caused by misregulated extracellular proteolysis. HAI-1 contains two Kunitz-type inhibitor domains (Kunitz), which are generally thought of as a functionally self-contained protease inhibitor unit. This is not the case for HAI-1, where our results reveal how interdomain interactions have evolved to stimulate the inhibitory activity of an integrated Kunitz. Here we present an x-ray crystal structure of an HAI-1 fragment covering the internal domain and Kunitz-1. The structure reveals not only that the previously uncharacterized internal domain is a member of the polycystic kidney disease domain family but also how the two domains engage in interdomain interactions. Supported by solution small angle x-ray scattering and a combination of site-directed mutagenesis and functional assays, we show that interdomain interactions not only stabilize the fold of the internal domain but also stimulate the inhibitory activity of Kunitz-1. By completing our structural characterization of the previously unknown N-terminal region of HAI-1, we provide new insight into the interplay between tertiary structure and the inhibitory activity of a multidomain protease inhibitor. We propose a previously unseen mechanism by which the association of an auxiliary domain stimulates the inhibitory activity of a Kunitz-type inhibitor (i.e. the first structure of an intramolecular interaction between a Kunitz and another domain).
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cell surface protein; inhibition mechanism; multidomain protein; protease inhibitor; protein-protein interaction; tertiary structure

Mesh:

Substances:

Year:  2016        PMID: 27189939      PMCID: PMC4933187          DOI: 10.1074/jbc.M115.707240

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

2.  Global rigid body modeling of macromolecular complexes against small-angle scattering data.

Authors:  Maxim V Petoukhov; Dmitri I Svergun
Journal:  Biophys J       Date:  2005-05-27       Impact factor: 4.033

3.  Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1.

Authors:  Kimitoshi Denda; Takeshi Shimomura; Toshiya Kawaguchi; Keiji Miyazawa; Naomi Kitamura
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

4.  Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.

Authors:  Steven Shia; Jennifer Stamos; Daniel Kirchhofer; Bin Fan; Judy Wu; Raquel T Corpuz; Lydia Santell; Robert A Lazarus; Charles Eigenbrot
Journal:  J Mol Biol       Date:  2005-01-28       Impact factor: 5.469

5.  Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form.

Authors:  T Shimomura; K Denda; T Kawaguchi; K Matsumoto; K Miyazawa; N Kitamura
Journal:  J Biochem       Date:  1999-11       Impact factor: 3.387

6.  Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers.

Authors:  Sylvia Herter; Derek E Piper; Wade Aaron; Timothy Gabriele; Gene Cutler; Ping Cao; Ami S Bhatt; Youngchool Choe; Charles S Craik; Nigel Walker; David Meininger; Timothy Hoey; Richard J Austin
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

7.  Archaeal surface layer proteins contain beta propeller, PKD, and beta helix domains and are related to metazoan cell surface proteins.

Authors:  Hua Jing; Junichi Takagi; Jin-huan Liu; Sara Lindgren; Rong-guang Zhang; A Joachimiak; Jia-huai Wang; Timothy A Springer
Journal:  Structure       Date:  2002-10       Impact factor: 5.006

8.  Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment.

Authors:  H Kataoka; T Shimomura; T Kawaguchi; R Hamasuna; H Itoh; N Kitamura; K Miyazawa; M Koono
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

9.  Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk.

Authors:  C Y Lin; J Anders; M Johnson; R B Dickson
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

10.  Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.

Authors:  Daniel Kirchhofer; Mark Peek; Wei Li; Jennifer Stamos; Charles Eigenbrot; Saloumeh Kadkhodayan; J Michael Elliott; Racquel T Corpuz; Robert A Lazarus; Paul Moran
Journal:  J Biol Chem       Date:  2003-06-18       Impact factor: 5.157

View more
  7 in total

1.  Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors.

Authors:  Trine Tamberg; Zebin Hong; Daphné De Schepper; Signe Skovbjerg; Daniel M Dupont; Lars Vitved; Christine R Schar; Karsten Skjoedt; Lotte K Vogel; Jan K Jensen
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

2.  The crystal structure of a multidomain protease inhibitor (HAI-1) reveals the mechanism of its auto-inhibition.

Authors:  Min Liu; Cai Yuan; Jan K Jensen; Baoyu Zhao; Yunbin Jiang; Longguang Jiang; Mingdong Huang
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

3.  Biochemical and structural analyses suggest that plasminogen activators coevolved with their cognate protein substrates and inhibitors.

Authors:  Agnieszka Jendroszek; Jeppe B Madsen; Andrés Chana-Muñoz; Daniel M Dupont; Anni Christensen; Frank Panitz; Ernst-Martin Füchtbauer; Simon C Lovell; Jan K Jensen
Journal:  J Biol Chem       Date:  2019-01-16       Impact factor: 5.157

4.  Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1.

Authors:  Tomohiro Ishikawa; Yayoi Kimura; Hisashi Hirano; Shouichi Higashi
Journal:  J Biol Chem       Date:  2017-10-18       Impact factor: 5.157

5.  Differential subcellular distribution renders HAI-2 a less effective protease inhibitor than HAI-1 in the control of extracellular matriptase proteolytic activity.

Authors:  Yi-Lin Chiu; Yi-Ying Wu; Robert B Barndt; Yu-Wen Lin; Hou-Ping Sytwo; Amy Cheng; Kacy Yang; Khee-Siang Chan; Jehng-Kang Wang; Michael D Johnson; Chen-Yong Lin
Journal:  Genes Dis       Date:  2020-12-09

6.  Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.

Authors:  Aaron C Mitchell; Deepti Kannan; Sean A Hunter; R Andres Parra Sperberg; Cheryl H Chang; Jennifer R Cochran
Journal:  J Biol Chem       Date:  2018-01-31       Impact factor: 5.157

7.  Understanding HAIs: Ally proteins in the fight against cancer.

Authors:  Annika W Nonboe; Zuzanna H Bald; Lotte K Vogel
Journal:  FEBS J       Date:  2022-02-27       Impact factor: 5.622

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.